Insomnia: Personalized Diagnosis and Treatment Options
- PMID: 36400549
- DOI: 10.1016/j.ncl.2022.07.004
Insomnia: Personalized Diagnosis and Treatment Options
Abstract
Chronic insomnia is a clinical diagnosis fulfilled by criteria: (a) difficulty initiating or maintaining sleep, (b) inability to sleep despite having adequate opportunities, (c) having negative daytime effects due to lack of sleep, and (d) sleep difficulty not explained by other disorder-with symptoms at least three times per week during a period of 3 months. Cognitive behavioral therapy is considered a first-line treatment but can be supported with pharmacologic or digital therapeutics. When developing a patient's care plan, we should consider a "personomics" approach in which we personalize care plans as a form of sleep precision medicine.
Keywords: Cognitive behavioral therapy; Insomnia; Personomics; Sleep; Somnomics.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure Dr. K.A. Porosnicu Rodriguez has no disclosures. Dr. R.M.E. Salas has the following disclosures: Idorsia, Alliance for Sleep (2022-present); HMP Global, Neurology and Sleep Education Consultant (2021-present); American Medical Association, Health System Science Core Faculty (2021-present); ScholarRX, Editorial Board, Education Consulting (2021-present); UptoDate Chapter-royalty (2016-present). Dr. L. Schneider reports personal fees from Jazz Pharmaceuticals, personal fees from Harmony Biosciences outside the submitted work, and employment at Alphabet, Inc.
Similar articles
-
Insomnia.Prim Care. 2024 Jun;51(2):299-310. doi: 10.1016/j.pop.2024.02.002. Epub 2024 Mar 13. Prim Care. 2024. PMID: 38692776 Review.
-
Precision Medicine for Insomnia.Sleep Med Clin. 2019 Sep;14(3):291-299. doi: 10.1016/j.jsmc.2019.04.001. Epub 2019 Jun 5. Sleep Med Clin. 2019. PMID: 31375199 Review.
-
Insomnia.Continuum (Minneap Minn). 2020 Aug;26(4):1003-1015. doi: 10.1212/CON.0000000000000879. Continuum (Minneap Minn). 2020. PMID: 32756233 Review.
-
Diagnosis and treatment of insomnia.Am J Health Syst Pharm. 2008 May 15;65(10):927-34. doi: 10.2146/ajhp060640. Am J Health Syst Pharm. 2008. PMID: 18463341 Review.
-
Diagnosis and management of insomnia.Clin Cornerstone. 2000;2(5):28-38. doi: 10.1016/s1098-3597(00)90038-3. Clin Cornerstone. 2000. PMID: 10875044 Review.
Cited by
-
The Abnormal N-Acetylaspartate to Creatine Ratio of the Right Putamen is Linked to Wakefulness in Patients with Insomnia Disorder.Nat Sci Sleep. 2024 Sep 19;16:1407-1418. doi: 10.2147/NSS.S468269. eCollection 2024. Nat Sci Sleep. 2024. PMID: 39318395 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical